MDS Virtual Congress 2021 » Dystonia: Clinical Trials and Therapy

A Double Blind, Placebo Controlled, Crossover Study of Incobotulinumtoxin-A in Musician’s Focal Hand Dystonia

S. Frucht, A. Nmashie, MC. George, C. Wu, A. Pantelyat, E. Altenmüller, M. Chen, D. Feng, DM. Simpson (New York, USA)

A Phase 3 Trial Evaluating the Efficacy, Duration of Effect, and Safety of DaxibotulinumtoxinA for Injection in the Treatment of Cervical Dystonia

J. Jankovic, C. Comella, R. Hauser, A. Patel, T. Gross, R. Rubio, D. Vitarella (Houston, USA)

A real-life study of Medical Cannabis effect on adults with dystonia

S. Anis, A. Faust-Socher, D. Sverdlov, N. Hezi, N. Giladi, T. Gurevich (Tel Aviv, Israel)

Approaching the lateral pterygoid muscle in botulinum toxin injections. How to avoid the maxillary artery

S. Unal, T. Karaarslan-Turk, C. Akbostanci, E. Peker, R. Yilmaz (Ankara, Turkey)

Benefits of Treatment with OnabotulinumtoxinA in Naive and Non-naive Patients with Cervical Dystonia are Sustained over Time: Preliminary Completer Analysis from CD PROBE

P. Agarwal, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)

Botulinum Toxin Injections For Movement Disorders During the COVID-19 Pandemic: A Single-Center Experience

B. Dorfman, M. Velickovic, W. Tse (New York, USA)

Cluster headache associated with secondary unilateral blepharospasm : A Case Report

P. Dugani, A. Mehta, P. R, M. Javali, P. Acharya, R. Srinivasa (Bengaluru, India)

COMPARISON OF ELECTROPHYSIOLOGIC AND ULTRASOUND GUIDANCE FOR ONABOTULINUM TOXIN-A INJECTIONS IN FOCAL UPPER EXTREMITY SPASTICITY AND DYSTONIA

C. Lungu, A. Nmashie, MC. George, T. Wu, S. Shin, B. Karp, E. Considine, W. Tse, S. Frucht, C. Wu, V. Koo, G. Norato, K. Alter, M. Hallet, DM. Simpson ()

Current perspectives on the management of cervical dystonia among global clinicians

H. Jinnah, H. Ferraz, S. Standal, P. Fattahi, A. Zuzek, N. Alibhai, K. Merath (Atlanta, USA)

Does Microneedle Use for Facial Injection of Botulinum Toxin Reduce Pain? A Systematic Literature Review

S. Maytharakcheep (Bangkok, Thailand)

Efficacy and safety of Botulinum toxin (BoNT) in lingual dystonia

D. Nene, S. Cresswell (Vancouver, Canada)

Impact of Disease Severity on Presentation Subtype and OnabotulinumtoxinA Utilization in Patients with Cervical Dystonia: Results from the CD PROBE Completer Population

P. Agarwal, R. Barbano, H. Moore, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)

Improvement of non-motor symptoms and quality of life after DBS stimulation for refractory dystonia: a one-year follow-up

C. Listik, R. Cury, S. Casagrande, E. Listik, D. Arnaut, N. Santiago, J. Machado, J. de Almeida, E. Barbosa, M. Teixeira, D. de Andrade (Sao Paulo, Brazil)

Injections of incobotulinumtoxinA at intervals less than 10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard injection intervals

C. Comella, R. Hauser, S. Isaacson, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, D. Charles (New Philadelphia, USA)

Pain and symptom management in a case of cervical dystonia with comorbid generalized joint hypermobility using prolotherapy with osteopathic manipulative medicine

J. Mancini, D. Whitfield (Old Westbury, USA)

Pain in cervical dystonia: A meta-analysis of outcomes following treatment with abobotulinumtoxinA in randomized, controlled clinical studies

R. Rosales, L. Cuffe, B. Regnault, R. Trosch (Manila, Philippines)

Tele-yoga for individuals with cervical dystonia: A pilot study

A. James-Palmer, J. Daneault (Newark, USA)

The feasibility of using an internet-based cognitive behavioural therapy programme as an intervention for people diagnosed with adult-onset, focal, isolated, idiopathic cervical dystonia

M. Wadon, M. Winter, K. Peall (Cardiff, United Kingdom)

The main reasons for essential blepharospasm botulinum neurotoxin (BoNT) treatment discontinuation in Latvian population.

K. Lazdovska, R. Valante (Riga, Latvia)

Treatment of cervical dystonia using shorter incobotulinumtoxinA injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals

S. Isaacson, D. Charles, C. Comella, D. Truong, O. Oguh, J. Hui, E. Molho, M. Brodsky, E. Furr-Stimming, G. Comes, M. Hast, R. Hauser (Boca Raton, USA)